ImmunityBio (IBRX) EBIT (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.90% |
| Dec 31, 2025 | -16.27% |
| Sep 30, 2025 | 21.96% |
| Jun 30, 2025 | -10.64% |
| Mar 31, 2025 | 7.16% |
| Dec 31, 2024 | 13.52% |
| Sep 30, 2024 | 19.21% |
| Jun 30, 2024 | -4.35% |
| Mar 31, 2024 | -11.49% |
| Dec 31, 2023 | -6.56% |
| Sep 30, 2023 | 5.88% |
| Jun 30, 2023 | 23.69% |
| Mar 31, 2023 | -31.43% |
| Dec 31, 2022 | 6.50% |
| Sep 30, 2022 | -14.04% |
| Jun 30, 2022 | 17.04% |
| Mar 31, 2022 | -21.06% |
| Dec 31, 2021 | -0.56% |
| Sep 30, 2021 | 8.23% |
| Jun 30, 2021 | 0.42% |
| Mar 31, 2021 | -179.30% |
| Dec 31, 2020 | 53.12% |
| Sep 30, 2020 | -29.38% |
| Jun 30, 2020 | -38.73% |
| Mar 31, 2020 | -127.81% |
| Dec 31, 2019 | -0.29% |
| Sep 30, 2019 | 7.12% |
| Jun 30, 2019 | 5.67% |
| Mar 31, 2019 | -3.48% |
| Dec 31, 2018 | 26.50% |
| Sep 30, 2018 | 14.75% |
| Jun 30, 2018 | 0.02% |
| Mar 31, 2018 | -11.38% |
| Dec 31, 2017 | -3.89% |
| Sep 30, 2017 | -2.61% |
| Jun 30, 2017 | 6.46% |
| Mar 31, 2017 | -1.28% |
| Dec 31, 2016 | 23.29% |
| Sep 30, 2016 | 6.26% |
| Jun 30, 2016 | -10.59% |
| Mar 31, 2016 | -5.66% |
| Dec 31, 2015 | 35.59% |
| Sep 30, 2015 | 64.37% |
| Jun 30, 2015 | -306.20% |
| Mar 31, 2015 | -1,119.64% |
| Dec 31, 2014 | -186.40% |
| Sep 30, 2014 | 23.29% |
| Jun 30, 2014 | -45.04% |